Yarlagadda S. Babu is VP at BIOCRYST PHARMACEUTICALS INC (BCRX). They have made 12 open-market trades across 1 company since 2009, most recently 2022-11-14.
CIK 0001452635
1 open-market purchase totalling $36K since 2019, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCRX | 298,541 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2022-11-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCRX | SELL | 2022-11-14 | 2022-11-16 | $13.88 | $875K | -0.6% | -13.9% | -18.6% |
| BCRX | SELL | 2022-03-07 | 2022-03-09 | $17.16 | $343K | -13.0% | -38.7% | -40.5% |
| BCRX | SELL | 2021-12-07 | 2021-12-09 | $12.20 | $367K | +12.1% | +23.0% | +53.5% |
| BCRX | BUY | 2019-11-18 | 2019-11-18 | $1.45 | $36K | +60.1% | +77.5% | +64.3% |
| BCRX | SELL | 2016-08-25 | 2016-08-29 | $4.06 | $244K | +4.3% | +13.3% | +37.1% |
| BCRX | SELL | 2015-03-19 | 2015-03-20 | $10.16 | $123K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2015-03-05 | 2015-03-06 | $10.59 | $396K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2015-03-04 | 2015-03-05 | $10.50 | $110K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2014-03-04 | 2014-03-07 | $12.57 | $511K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2012-03-02 | 2012-03-05 | $4.78 | $4K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2012-02-22 | 2012-02-23 | $4.22 | $130K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL · 10b5-1 | 2009-10-26 | 2009-10-28 | $10.85 | $69K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL · 10b5-1 | 2009-10-21 | 2009-10-22 | $10.00 | $2K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL · 10b5-1 | 2009-10-20 | 2009-10-21 | $10.00 | $34K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2009-09-23 | 2009-09-24 | $9.14 | $183K | -26.4% | -2.7% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.